Personalized drug therapy with pharmacogenetics--part 2: pharmacodynamics.
Howland
Robert H
RH
University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pennsylvania 15213, USA. HowlandRH@upmc.edu
D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001665:Binding Sites; D001921:Brain / Q000378:metabolism; D004298:Dopamine / Q000235:genetics* / Q000378:metabolism*; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D050479:Neurotransmitter Transport Proteins / Q000235:genetics / Q000378:metabolism; D010597:Pharmacogenetics / Q000379:methods*; D012701:Serotonin / Q000235:genetics* / Q000378:metabolism*
D014150:Antipsychotic Agents; D050479:Neurotransmitter Transport Proteins; D012701:Serotonin; D004298:Dopamine